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Self-managed, computerised  
word finding therapy as an add-on  
to usual care for chronic  
aphasia post-stroke:  
An economic evaluation
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Abstract
Objective: To examine the cost-effectiveness of self-managed computerised word finding therapy as an 
add-on to usual care for people with aphasia post-stroke.
Design: Cost-effectiveness modelling over a life-time period, taking a UK National Health Service (NHS) 
and personal social service perspective.
Setting: Based on the Big CACTUS randomised controlled trial, conducted in 21 UK NHS speech and 
language therapy departments.
Participants: Big CACTUS included 278 people with long-standing aphasia post-stroke.
Interventions: Computerised word finding therapy plus usual care; usual care alone; usual care plus 
attention control.
Main measures: Incremental cost-effectiveness ratios (ICER) were calculated, comparing the cost 
per quality adjusted life year (QALY) gained for each intervention. Credible intervals (CrI) for costs 
and QALYs, and probabilities of cost-effectiveness, were obtained using probabilistic sensitivity analysis. 
Subgroup and scenario analyses investigated cost-effectiveness in different subsets of the population, and 
the sensitivity of results to key model inputs.
Results: Adding computerised word finding therapy to usual care had an ICER of £42,686 per QALY 
gained compared with usual care alone (incremental QALY gain: 0.02 per patient (95% CrI: −0.05 to 0.10); 
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incremental costs: £732.73 per patient (95% CrI: £674.23 to £798.05)). ICERs for subgroups with mild or 
moderate word finding difficulties were £22,371 and £21,262 per QALY gained respectively.
Conclusion: Computerised word finding therapy represents a low cost add-on to usual care, but QALY 
gains and estimates of cost-effectiveness are uncertain. Computerised therapy is more likely to be cost-
effective for people with mild or moderate, as opposed to severe, word finding difficulties.
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Introduction
Aphasia is a language disorder which causes prob-
lems with reading, writing, talking and/or under-
standing spoken language.1 Aphasia can restrict 
participation in work, family and community life. 
Approximately 33% of people who have a stroke 
experience aphasia, and 30%–43% of these remain 
significantly affected in the long-term.2 However, 
people with aphasia can improve with speech and 
language therapy,3 and acceptability and demand 
for ongoing therapy is high,4 but availability can be 
limited around the world due to staffing and budg-
etary constraints.5–7
A computerised approach to word finding ther-
apy (hereafter referred to as computerised therapy) 
has the potential to increase access to speech and 
language therapy, because it enables patients to 
self-manage repetitive language exercises without 
the presence of a speech and language therapist. 
This may be particularly helpful in health systems 
with constrained resources. Many health systems 
use economic evaluation to ensure that limited 
healthcare budgets are allocated efficiently.
Big CACTUS (Cost effectiveness of Aphasia 
Computer Therapy versus Usual care or attention 
control post Stroke) represented the first multicen-
tre randomised controlled trial (RCT) investigating 
computer therapy for word finding in aphasia.8 The 
trial built on an earlier pilot trial, named CACTUS.9 
An economic evaluation undertaken alongside the 
CACTUS pilot trial indicated that computerised 
therapy may represent a cost-effective use of health-
care resources, but was highly uncertain due to the 
small sample size – it was concluded that further 
research was necessary.10 Big CACTUS found that 
adding computerised therapy to usual care statisti-
cally and clinically significantly improved word 
finding ability but the effect did not generalise to 
measures of conversation.11,12 Improved ability to 
find words represents an important step towards 
improved communication and therefore – despite 
the need for further research related to methods of 
generalising the effect to conversation – we sought 
to use evidence from Big CACTUS to undertake an 
updated economic evaluation investigating the 
long-term cost-effectiveness of adding computer-




Big CACTUS was a pragmatic, superiority, 
observer-blinded, parallel group, RCT conducted 
in 21 UK NHS speech and language therapy depart-
ments. Participants were recruited between Oct 20, 
2014 and Aug 18, 2016, and were followed up 
between Oct 24, 2015 and Sept 12, 2017. The trial 
was registered with the ISRCTN registry [number 
ISRCTN68798818]. Ethics approval was obtained 
from Leeds West NHS research ethics committee 
[reference 13/YH/0377] and Scotland A research 
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ethics committee [reference 14/SS/0023] and writ-
ten informed consent was obtained from partici-
pants or their carers.11,12 The trial was funded by 
the National Institute for Health Research (NIHR) 
[reference 12/21/01] and the Tavistock Trust for 
Aphasia. The trial protocol is publicly available8 
and specific details on clinical aspects of the study 
can be found in an extensive report for the funder 
(which also includes full details of the economic 
evaluation),11 and have been summarised else-
where.12 The CACTUS pilot study was also regis-
tered with the ISRCTN registry [number 
ISRCTN91534629], was funded by the NIHR [ref-
erence PB-PG-1207-14097], and clinical and cost-
effectiveness results are published.9,13
In Big CACTUS, participants were ran-
domised into three groups: (1) computerised 
word finding therapy plus usual care, (2) atten-
tion control plus usual care and (3) usual care 
alone. Computerised therapy involved aphasia 
therapy software (StepByStep©) tailored to the 
participant’s language impairment needs and per-
sonalised with 100 words relevant to the partici-
pant by a speech and language therapist. The 
participant was encouraged to practise word find-
ing for six months on a daily basis. The interven-
tion included monthly support from a speech and 
language therapist assistant or volunteer. The 
attention control group received puzzle books 
and monthly supportive telephone calls. Usual 
care (including speech and language therapy) 
continued to be provided to patients in all inter-
vention groups, so that the effectiveness of com-
puterised therapy as an addition to usual care 
could be assessed, rather than investigating com-
puterised therapy as a replacement for usual care.
Participants had aphasia confirmed by a speech 
and language therapist after one or more strokes at 
least four months before randomisation – though 
many experienced their stroke much longer ago; 
the median time post stroke was approximately 
two years. Participants had word finding difficul-
ties (defined by a score of 5–43/48 on the 
Comprehensive Aphasia Test (CAT) Naming 
Objects test14), could perform a simple matching 
task on StepByStep© software with at least 50% 
accuracy, and could repeat at least 50% of words 
in a repetition task on StepByStep©. The average 
age of participants was 65 years.
Economic evaluation of computerised 
therapy: Overview
A model-based cost-utility analysis was conducted 
in line with recommendations made by the National 
Institute for Health and Care Excellence (NICE), 
the UK health technology assessment agency,15 
taking a UK NHS and personal social services per-
spective (where personal social services refer to 
services provided by local authorities which are 
funded by the NHS). Due to the potentially long-
lasting effects of the intervention a lifetime horizon 
was modelled, meaning that the patient experience 
was modelled until all patients were projected to 
have died. The incremental costs and benefits of 
the treatment arms evaluated in Big CACTUS were 
assessed, and the population modelled was that 
included in Big CACTUS. Therefore clinical effec-
tiveness estimates (and distributions around these 
estimates) were taken from the clinical measures 
used in the trial.11
In line with NICE recommendations,15 benefits 
were calculated in terms of quality adjusted life 
years (QALYs) which combine length of life and 
health-related quality of life into one measure. The 
costs and QALYs associated with each treatment 
option were compared and combined into incre-
mental cost-effectiveness ratios (ICERs). ICERs 
express as a ratio the incremental costs of a new 
intervention relative to the incremental QALYs it 
produces: therefore, we estimated the incremental 
cost of computerised therapy plus usual care com-
pared to usual care alone, and estimated the incre-
mental QALY gain associated with computerised 
therapy plus usual care compared to usual care 
alone, and distilled these estimates into a ratio: the 
incremental cost per QALY gained, also known as 
the ICER. We did the same for the comparison of 
computerised therapy plus usual care compared to 
attention control plus usual care, and therefore 
obtained ICERs for computerised therapy plus 
usual care compared to usual care alone, and com-
pared to attention control plus usual care. ICERs 
were compared to thresholds used by NICE to aid 
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decision making. NICE typically considers inter-
ventions to be cost-effective if the ICER is less 
than £20,000–£30,000 per QALY gained ($26,023–
$39,035 in United States Dollars, at an exchange 
rate of £1:$1.30).15
The economic model incorporated several 
assumptions and model inputs (e.g. around treat-
ment effectiveness, costs and quality of life), to be 
described in subsequent sections. We conducted a 
‘base-case’ analysis which incorporated our pre-
ferred assumptions for each model input and mod-
elled the full patient population included in Big 
CACTUS. However, recognising that some model 
inputs were particularly uncertain, we conducted a 
series of pre-specified secondary analyses, specifi-
cally around different cost assumptions and differ-
ent methods for estimating health-related quality of 
life scores. We also conducted pre-specified sub-
group analyses for subsets of the Big CACTUS 
population. Subgroup analyses for word finding 
difficulty at baseline (mild/moderate/severe, iden-
tified using scores from the CAT Naming Objects 
test at baseline) are presented here. Other subgroup 
analyses (Comprehension ability subgroups; Time 
since stroke subgroups) are reported elsewhere.11
Model structure
A Markov model was used. This is a commonly 
used type of economic model that consists of a series 
of ‘health states’, representing disease status.16 
People move between the health states over time, 
allowing key changes in disease status to be mod-
elled (Figure 1). The model begins with all people in 
Figure 1. Markov model structure.
Each oval represents a health state. Participants begin in the ‘Aphasia’ health state and transition through the model in three-
month cycles according to data on response and relapse from Big CACTUS. Arrows illustrate possible pathways through the 
model. Health states coloured in green represent ‘tunnel states’, which means that participants can only reside in these states for 
one modelled cycle before transitioning to a different health state. Death could occur from any health state. No new responses 
were assumed to occur after 12 months – from that point onwards participants in the ‘Good response (12 months and beyond)’ 
health state either retain a good response, relapse to the ‘Aphasia’ health state or die. From 12 months onwards people in the 
‘Aphasia’ health state either remain in that health state or die.
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the ‘Aphasia’ health state. Every three months, peo-
ple were modelled to move between the different 
health states in the model (‘Aphasia’; ‘Good 
response’; ‘Dead’), or remain in their existing health 
state (i.e. a three month cycle length was used). 
Death could occur from any health state. For the first 
12 months of the model, people transitioned through 
the model according to clinical effectiveness data 
from Big CACTUS, which collected outcomes data 
at six, nine and 12 month time-points. For instance, a 
participant who, according to Big CACTUS data, 
had a good response at six months, would be placed 
in the ‘Good response (six months)’ health state at 
the six-month time-point in the model. The ‘Good 
response (six months)’ health state is a ‘tunnel’ state, 
which means that people could only spend three 
months (one modelled cycle) in it. At the following 
modelled time point (nine months, given the three-
month cycle length used), the participant could 
either maintain their good response and move into 
the ‘Good response (nine months)’ health state, 
could relapse to the ‘Aphasia’ health state or could 
die. The ‘Good response (nine months)’ health state 
is also a ‘tunnel’ state, so people could only spend 
three months (one modelled cycle) in it. So, a par-
ticipant with a good response at nine months could 
either retain that response and move into the ‘Good 
response (12 months and beyond)’ health state in the 
following modelled cycle, could relapse to the 
‘Aphasia’ health state, or could die. Big CACTUS 
did not measure outcomes after 12 months, and so 
we assumed no new responses beyond this time-
point. Hence, a patient who had not achieved a good 
response at the 12 month time-point would remain in 
the ‘Aphasia’ health state until death. A patient with 
a good response measured at 12 months could subse-
quently maintain that response and remain in the 
‘Good response (12 months and beyond)’ health 
state, could relapse to the ‘Aphasia’ health state, or 
could die.
Model parameters
A good response was characterised as a clinically 
meaningful improvement (from baseline) in either 
of the co-primary outcome measures included in 
Big CACTUS, pre-specified as an increase of 10% 
or more in words found correctly on a naming test 
of 100 personally relevant words, and/or an 
increase of 0.5 points or more on the Therapy 
Outcomes Measures activity scale.17 This was pre-
specified in the publicly available health econom-
ics analysis plan,17 as it was considered that any 
patient who achieved either of these improvements 
could be considered to have responded well to 
treatment. Model transitions from the ‘Good 
response’ health states back to the ‘Aphasia’ health 
state were determined by an analysis of the chang-
ing response proportions over time observed in 
each treatment arm of Big CACTUS.
Beyond 12 months (the final data collection 
point in Big CACTUS), we assumed that no new 
good responses occurred in any treatment arm. The 
relapse rate observed between nine and 12 months 
was assumed to remain constant for the remainder 
of the modelled period, hence we assumed that 
good responses were lost over time.
A proportion of participants were assumed to 
die in each model cycle, based on post-stroke death 
rates combined with age-related mortality risks.18,19 
Mortality rates were the same in each health state 
of the model and for each intervention – therefore 
it was assumed that the interventions under consid-
eration did not affect mortality or life expectancy. 
Mortality rates in the economic model simply 
reflect expected death rates post-stroke over time.
Health related quality of life
NICE recommends the EQ-5D questionnaire to 
measure health-related quality of life for economic 
evaluation.15 In Big CACTUS an accessible (pic-
ture-based) version of the EQ-5D-5L questionnaire 
was administered to enable participants to under-
stand the questions, and respond themselves20,21; 
this measure was informed by people with aphasia 
but is not yet psychometrically validated.
Responses to the accessible EQ-5D-5L question-
naire were combined with an algorithm developed 
by Van Hout et al.22 to calculate utility scores (a 
score describing health-related quality of life on a 
scale of 1 to −0.594, where a score of 1 represents 
perfect health and a score of 0 represents death). A 
utility score was assigned to the ‘Aphasia’ health 
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state in the economic model, and utility increments 
(or decrements) were applied to the ‘Good response’ 
health states at six months, nine months and 
12 months according to the difference in utility 
score change from baseline, between those in the 
‘Good response’ state and those in the ‘Aphasia’ 
state. The utility increment associated with a good 
response at 12 months was extrapolated for the 
remainder of the modelled period. Utility scores 
were reduced over time to account for ageing.23 In 
each three-month cycle of the economic model, 
participants accrue QALYs according to the utility 
score of the health state that they reside in (e.g. 
spending three months in a health state with a utility 
score of 0.8 would accrue 0.2 QALYs (0.8 × 3/12)). 
QALYs were estimated in this way for the duration 
of the economic model, allowing total QALYs asso-
ciated with each treatment strategy to be calculated. 
QALYs were discounted at an annual rate of 3.5%, 
according to NICE recommendations.15 Discounting 
is included in economic evaluation because benefits 
and costs that are incurred in the present are usually 
valued more highly than benefits and costs occur-
ring in the future – discounting benefits reflects 
society’s preference for benefits to be experienced 
sooner rather than later.15
The EQ-5D-5L questionnaire is the latest version 
of the EQ-5D instrument, developed in 2011,24 
which contains five questions about health-related 
quality of life, with five levels of response for each 
question. The EQ-5D-3L questionnaire was devel-
oped in the 1990s and contains five similar ques-
tions, with three levels of response for each 
question.25 The EQ-5D-5L has the advantage of an 
increased number of possible responses and so may 
be more sensitive, but there is currently disagree-
ment about how to estimate utility scores (i.e. health-
related quality of life scores) from it. A ‘tariff’ exists, 
allowing EQ-5D-5L questionnaire responses to be 
transformed into a utility score,26 but there are con-
cerns about its validity.22,27 Therefore, NICE27 rec-
ommends using a mapping algorithm developed by 
Van Hout et al.22 to estimate utility scores using the 
EQ-5D-3L tariff from responses to the EQ-5D-5L 
questionnaire. We used the Van Hout et al.22 algo-
rithm in our base-case analysis, but, recognising the 
disagreement around this, conducted pre-planned 
secondary analyses using alternative approaches. 
These included using the EQ-5D-5L tariff for 
England (developed by the Office for Health 
Economics (OHE)),26 and using an alternative map-
ping algorithm developed by Hernandez-Alava 
et al.28 which, like the Van Hout et al.27 algorithm, 
maps EQ-5D-5L questionnaire responses onto the 
EQ-5D-3L tariff to calculate utility scores.
Often economic analyses are conducted using 
proxy reports when participants are unable to com-
plete standard health-related quality of life ques-
tionnaires. Hence, in an additional secondary 
analysis, we used utility scores calculated from 
standard EQ-5D-5L questionnaire responses com-
pleted on behalf of Big CACTUS participants by 
their informal carers.
Resource use and costs
Costs included were consistent with the NHS and 
personal social services perspective taken. For 
computerised therapy, costs included computers 
and headsets (for those who needed these on loan 
from the NHS), StepByStep© software, time spent 
by speech and language therapists and assistants 
delivering – and being trained to deliver – the 
intervention, and travel costs. Attention control 
costs included puzzle books and a staff member’s 
time spent phoning participants each month. Data 
on these were collected in Big CACTUS using 
activity logs11 and in our base-case analysis 
resource use estimates were based on these data. 
Because usual care was included in each of the 
intervention groups, we assumed that there would 
be no difference in these costs between treatment 
arms. Therefore, costs associated with usual care 
were not included in the economic evaluation.
Costs included were one-off and therefore were 
not extrapolated beyond the one-year trial period. 
In economic evaluation, costs that occur in the 
future are usually discounted to reflect society’s 
preference for costs to be incurred in the future 
rather than the present.15 However, when all costs 
are incurred in the first year of the analysis, costs 
are short-term and discounting is not required. The 
cost year was 2016/17. National unit costs were 
used to value resource uses29 (Table 1).
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We considered it possible that over time speech 
and language therapists and assistants would 
become more familiar with the software, and, con-
sequently, would require less time to set-up and 
deliver computerised therapy. To represent this 
scenario, we ran a secondary analysis in which 
speech and language therapist and assistant costs 
were halved.
Missing data
Data was missing for some of the clinical meas-
ures assessed in Big CACTUS (e.g. because some 
participants did not complete all questionnaires at 
some time-points). Where data are missing, it is 
common to impute what the missing values might 
have been, taking into account uncertainty around 
these imputations.31,32 Missing data for EQ-5D-5L 
utility scores and co-primary outcome scores was 
imputed with multiple imputation using a tech-
nique called predictive mean matching,31,32 
described fully elsewhere.11
Probabilistic analysis
Analyses were undertaken allowing for uncertainty 
in all of the model inputs (i.e. health state transition 
probabilities, utility (health-related quality of life) 
scores, resource use (cost) estimates) – that is, the 
analyses were undertaken ‘probabilistically’. For 
instance, our analysis of the response rates observed 
in Big CACTUS provides an estimate of the prob-
ability of achieving a ‘Good response’ for each 
treatment at each time point, but this estimate is not 
certain – thus requiring confidence intervals to be 
stated. Because the exact values of each parameter 
included in the economic model are unknown, 
probability distributions were placed around them 
and probabilistic analyses were used. This involved 
running the model thousands of times, each time 
randomly selecting a value from the distribution of 
each uncertain parameter in the model. Various dif-
ferent probability distributions exist – we used 
those typically used for model input parameters in 
economic modelling33: Normal distributions were 
Table 1. Unit costs.
Item description Unit cost (£) References Note
Laptop/tablet loan for six months (for 
participants without own computer)
69 Palmer et al.11 Unit cost calculated from 
average cost of a laptop/tablet 
purchased through the NHS 
(£690), divided by 10 users 
over shelf life.
StepbyStep© software individual licence 250 Steps Consulting Ltd30  
StepbyStep© software clinician licence 550 Steps Consulting Ltd30  
StepbyStep© software clinician 5-licence 
bundle
2200 Steps Consulting Ltd30  
Headsets 14.50 Palmer et al.11  
Puzzle books 2.50 Palmer et al.11  
SLT band 7 cost/minute 0.90 Curtis and Burns29 Delivery of computerised 
therapy training
SLT band 6 cost/minute 0.75 Curtis and Burns29 Delivery of computerised 
therapy intervention
SLT band 5 cost/minute 0.57 Curtis and Burns29 Delivery of attention control 
intervention
SLTA band 3 cost/minute 0.41 Curtis and Burns29 Delivery of computerised 
therapy intervention
Travel cost/mile 0.45 Curtis and Burns29  
SLT: speech and language therapist; SLTA: speech and language therapy assistant; NHS: National Health Service.
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assigned to utility score change parameters, beta 
distributions to transition probabilities and gamma 
distributions to resource use parameters. The model 
was run 10,000 times for the base-case analysis and 
for each subgroup and secondary analysis. Each 
model run provided an estimate of the costs and 
QALYs associated with each intervention and the 
average estimates of incremental costs and QALYs 
were used to provide the best estimate of the incre-
mental cost per QALY gained (i.e. the ICER). We 
calculated 95% ‘credible intervals’ for incremental 
costs and QALYs, representing the interval within 
which the value of incremental costs and QALYs 
falls with a 95% probability. Cost-effectiveness 
planes and cost-effectiveness acceptability curves 
(CEACs) were used to graphically represent uncer-
tainty, and demonstrate the probability that the 
competing interventions represent a cost-effective 
use of healthcare resources.
Results
Model input parameters and 
probabilistic analysis
Supplemental Table 1 presents input parameters 
used in the model. Computerised therapy plus 
usual care resulted in the highest proportion of 
good responses. The estimated utility score change 
(i.e. the health-related quality of life change) asso-
ciated with a good response was negative at six 
months (–0.04, 95% CI: −0.09 to 0.01) and nine 
months (–0.02, 95% CI: −0.07 to 0.03), but was 
positive at 12 months (0.02, 95% CI: −0.03 to 
0.07). There was 1% missing data for the accessi-
ble EQ-5D-5L questionnaire at baseline, and 18% 
at 12 months. There were no missing data for cost 
variables.
Cost-effectiveness results
Table 2 presents results from the base-case analysis 
(representing our preferred assumptions for the full 
Big CACTUS population) and secondary analyses 
(representing alternative assumptions around key 
model inputs). In the base-case, the ICER for com-
puterised therapy plus usual care versus usual care 
alone was £42,686 ($55,541) per QALY gained 
(incremental cost per-patient £732.73 ($953.39) 
(95% Credible Interval (CrI) £674.23–£798.05 
($877.27–$1,038.38)); incremental QALY gain 
per-patient 0.02 (95% CrI −0.05 to 0.10)). For 
computerised therapy plus usual care versus atten-
tion control plus usual care, the ICER was £40,164 
($52,259) per QALY gained. Attention control plus 
usual care was more expensive and produced fewer 
QALYs than usual care alone (in economic terms it 
was ‘dominated’). Figure 2 depicts cost-effective-
ness planes and acceptability curves for the base-
case analysis. Using a £30,000 ($39,035) per 
QALY gained threshold, the probability that com-
puterised therapy plus usual care represents the 
most cost-effective treatment option was 32% 
(45% for usual care alone; 22% for attention con-
trol plus usual care).
Using different approaches to estimate utility 
scores resulted in markedly different ICERs, 
ranging from £28,819 ($37,498) to £55,639 
($72,395) per QALY gained for computerised 
therapy plus usual care compared to usual care 
alone (Table 2). Speech and language therapist 
time was the predominant cost driver – the 
7.13 hours per-patient spent setting up and sup-
porting computerised therapy contributed 44% of 
the total computerised therapy cost. Halving 
speech and language therapist and assistant costs 
reduced the ICER for computerised therapy plus 
usual care compared to usual care alone to £26,153 
($34,029) per QALY gained.
Subgroup analysis
ICERs for participants with mild and moderate 
word finding difficulties at baseline were 
£22,371 ($29,108) and £21,262 ($27,783) per 
QALY gained respectively, for the comparison 
of computerised therapy plus usual care with 
usual care alone (Table 3). Computerised ther-
apy plus usual care was more costly and less 
effective than usual care alone and attention con-
trol plus usual care for participants with severe 
word finding difficulty – in economic terms, in 
this subgroup computerised therapy plus usual 






Table 2. Cost-effectiveness results from base-case and secondary analyses – computerised therapy plus usual care compared to usual care alone, and 







Incremental cost [£]: 
Computerised therapy 















(£ per QALY 
gained)
Comparator: usual care alone
Base-case analysis 732.73 0.00 732.73 (674.23–798.05) 4.2164 4.1992 0.0172 (−0.05 to 0.10) 42,686
Using English EQ-5D-5L tariff 732.25 0.00 732.25 (673.19–797.84) 4.8537 4.8406 0.0132 (−0.04 to 0.09) 55,639
Using carer proxy EQ-5D-5L 733.06 0.00 733.06 (672.70–800.01) 3.5339 3.5084 0.0254 (−0.05 to 0.12) 28,819
Hernandez and Pudney28 EQ-
5D mapping
732.96 0.00 732.96 (672.60–798.22) 4.1568 4.1358 0.0210 (−0.04 to 0.11) 34,921
SLT/SLTA costs halved 448.92 0.00 448.92 (411.50–495.12) 4.2164 4.1992 0.0172 (−0.05 to 0.10) 26,153
Comparator: attention control plus usual care
Base-case analysis 732.73 38.14 694.59 (636.46–760.09) 4.2164 4.1991 0.0173 (−0.05 to 0.10) 40,164
Using English EQ-5D-5L tariff 732.25 38.17 694.09 (634.95–759.75) 4.8537 4.8402 0.0135 (−0.04 to 0.09) 51,308
Using carer proxy EQ-5D-5L 733.06 38.18 694.88 (634.58–761.87) 3.5339 3.5085 0.0254 (−0.05 to 0.12) 27,397
Hernandez and Pudney28 EQ-
5D mapping
732.96 38.18 694.78 (634.94–760.21) 4.1568 4.1356 0.0211 (−0.04 to 0.11) 32,835
SLT/SLTA costs halved 448.92 38.19 410.78 (373.09–457.72) 4.2164 4.1991 0.0173 (−0.05 to 0.10) 23,753
QALY: quality adjusted life year; ICER: incremental cost effectiveness ratio; SLT: speech and language therapist; SLTA: speech and language therapy assistant.
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Discussion
We demonstrate that, despite the (partial) clinical 
benefits observed in Big CACTUS, the cost-effec-
tiveness of adding computerised therapy to usual 
care remains uncertain. Our incremental cost-
effectiveness ratios are close to commonly 
accepted cost-effectiveness thresholds used in the 
United Kingdom. Fundamentally, it is unclear 
whether adding computerised therapy to usual 
care leads to a QALY gain compared to usual care 
alone. This is because the health-related quality of 
life benefit associated with a good response to 
computerised therapy was small and uncertain.
In Big CACTUS, adding computerised therapy to 
usual care led to a substantial, significant improvement 
Figure 2. Cost-effectiveness planes for computerised therapy plus usual care compared to (a) usual care alone and (b) 
attention control plus usual care, and (c) cost-effectiveness acceptability curves (CEACs) – base-case analysis.



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































in word finding ability compared to usual care alone 
and attention control plus usual care, but did not dem-
onstrate improvements in functional communication.11 
Improved word finding ability is represented in our 
economic model – more participants in the computer-
ised therapy plus usual care group entered the ‘good 
response’ health state. However, there was no clear 
health-related quality of life gain associated with a 
good response, which caused the highly uncertain cost-
effectiveness results. Given that computerised therapy 
was not found to improve functional communication in 
Big CACTUS, it is perhaps unsurprising that it did not 
result in clear improvements in health-related quality 
of life measured by the EQ-5D-5L questionnaire. A 
key challenge, and a priority area for further research, 
is to investigate ways in which improvements in word 
finding ability obtained through adding computerised 
therapy to usual care could be generalised into func-
tional improvements, which might result in appreciable 
QALY gains.
It is notable that, as part of the computerised 
therapy intervention, it was intended that therapy 
assistants or volunteers would practise tasks to pro-
mote the use of new words in context. However, 
these tasks were only carried out for an average of 
45 minutes per patient over the entire six month 
treatment period.12 This may have inhibited the 
generalisation of word finding improvements to 
functional conversation improvements, meaning 
that potential QALY gains were not realised.
Our analyses demonstrate that only very small 
QALY gains are required for adding computerised 
therapy to usual care to represent a cost-effective 
use of resources, because computerised therapy 
costs are low. The estimate of the QALY gain asso-
ciated with computerised therapy was 0.02 in the 
analysis for the full Big CACTUS population, and 
was 0.03 and 0.04 in the mild and moderate word 
finding difficulty subgroups respectively (with sub-
stantial confidence intervals around these values). 
This difference was enough to change the interpre-
tation of the cost-effectiveness results – the ICER 
was greater than NICE’s £30,000 ($39,035) per 
QALY gained threshold for the full Big CACTUS 
population, but was lower than that threshold in the 
mild and moderate word finding difficulty sub-
groups. Also, there is currently disagreement about 
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how to calculate health-related quality of life scores 
(and therefore QALYs) from the EQ-5D-5L ques-
tionnaire27 and, in our analyses, using different 
approaches resulted in markedly different cost-
effectiveness estimates. NICE27 currently recom-
mends the Van Hout et al.22 algorithm for calculating 
utility scores from the EQ-5D-5L questionnaire, but 
other options are available.26,28 The different 
approaches result in small differences in health-
related quality of life estimates, but in cases such as 
ours, where treatment costs are low, small changes 
in QALY estimates can lead to large changes in 
cost-effectiveness estimates.
The average cost of computerised therapy in 
Big CACTUS was £733 ($954) per participant. 
Speech and language therapists spent 7.13 hours on 
setup and support for each computerised therapy 
participant, and computerised therapy participants 
used the software for an average of 28 hours during 
the trial period.11 These costs are low: providing 
28 hours of face-to-face speech and language ther-
apy would cost approximately £1400 ($1822), 
almost twice as much as supporting an individual 
to practise independently with computerised ther-
apy – although the relative effectiveness of face-to-
face care is unknown.
There may be scope to further reduce the cost of 
computerised therapy, which could alter the con-
clusions of our cost-effectiveness analysis. If 
speech and language therapist and assistant costs 
could be halved, the ICER for adding computerised 
therapy to usual care compared to usual care alone 
would fall to £26,153 ($34,029) per QALY gained 
for the full Big CACTUS population. This may be 
possible – Big CACTUS participants were recruited 
between September 2014 and August 2016, when 
the StepByStep© software was new and had teeth-
ing issues and speech and language therapists were 
learning how to use it. Therapist support time and 
associated costs may be lower in an established 
clinical service. Whilst reducing therapist setup/
support time could improve the cost-effectiveness 
of computerised therapy, their oversight is likely to 
remain important. Potentially speech and language 
therapists could assume a consultative role, guid-
ing assistants and volunteers to personalise the 
software, and only adding more personally relevant 
words once a participant has demonstrated engage-
ment with the intervention with an initial limited 
word set. This is in contrast to the use of qualified 
speech and language therapist time to personalise 
large word sets immediately upon initiation of the 
intervention, as was the case in Big CACTUS.
Whilst cost savings in the delivery of comput-
erised therapy could be realised in reality, it is also 
possible that approaches for generalising word-
finding benefits to functional conversation (and 
QALY) improvements might require a broader 
package of care – and therefore increased costs. 
However, given the low cost of computerised ther-
apy, and the potential for increased benefits, such 
a package may represent a cost-effective use of 
healthcare resources.
The only previous evaluation of the cost-effec-
tiveness of computerised therapy for post-stroke 
aphasia was undertaken alongside the CACTUS 
pilot study. This resulted in a much lower ICER for 
computerised therapy plus usual care compared to 
usual care alone (£3,127 ($4,069) per QALY 
gained).10 This is primarily because the utility gain 
associated with a good response was estimated to be 
much higher using pilot study data (0.07 (CI −0.15 
to 0.29), compared to 0.02 (CI −0.03 to 0.07) using 
Big CACTUS data). Confidence intervals around 
this estimate have been reduced by Big CACTUS, 
but centre around the lower end of the interval esti-
mated in the pilot study. Consequently, the ICER 
estimated using Big CACTUS data is much higher 
than that estimated using pilot study data, and cost-
effectiveness estimates remain uncertain.
Our economic evaluation adhered to good prac-
tise guidelines and was based on a well-conducted 
full-scale RCT to enable a robust assessment of 
the cost-effectiveness of adding computerised 
therapy to usual care. A particular strength of the 
Big CACTUS study was the chronicity of the 
study participants – median time since stroke was 
approximately two years, and therefore the com-
puterised therapy intervention was truly tested on 
people who were experiencing aphasia long after 
stroke. In this context, the clinical results observed 
are particularly encouraging.
Using an accessible version of the EQ-5D-5L 
questionnaire represents both a strength and a 
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weakness of this study. It addressed concerns around 
the validity of the standard EQ-5D-5L questionnaire 
for people with aphasia20,21 and allowed health-
related quality of life data to be collected directly 
from patients, avoiding well-known issues associ-
ated with collecting such information by proxy.34 
However, further research should also assess 
whether the accessible version of the EQ-5D-5L 
questionnaire is a valid and responsive tool for 
measuring health-related quality of life in people 
with aphasia. The EQ-5D questionnaire was used in 
Big CACTUS and in our assessment of cost-effec-
tiveness because it is preferred by NICE.15 As 
opposed to disease-specific measures, generic, pref-
erence-based measures such as the EQ-5D question-
naire provide a basis for making consistent resource 
allocation decisions throughout health systems, but 
it might be argued that the EQ-5D questionnaire 
does not well represent the quality of life constructs 
that might be expected to change through improved 
communication. NICE recognises that in some cases 
the EQ-5D questionnaire may not be appropriate, 
but requires qualitative and empirical evidence to 
support such an argument.15 In addition, given that 
computerised therapy plus usual care did not lead to 
an improvement in functional communication as 
measured using Therapy Outcomes Measures in Big 
CACTUS, it is questionable whether any quality of 
life measure would have shown an improvement. 
Finally, self-managed therapy allows people to exer-
cise choice over their own health care – it is unclear 
whether this empowerment would be captured by 
disease-specific outcome measures, or by generic 
questionnaires such as the EQ-5D.
A limitation of our analysis is that only direct 
intervention costs associated with computerised 
therapy and attention control were included, imply-
ing an assumption of equal costs associated with 
usual care across the intervention groups. This 
assumption was made because the computerised 
therapy investigated in Big CACTUS was intended 
as an addition to usual care, rather than a replace-
ment for it, and usual care was maintained in each 
intervention group. However, we recognise that 
receiving computerised therapy could have an 
impact on other care received by people with apha-
sia. The CACTUS pilot study collected information 
on a wide range of resource use (such as medica-
tion, primary care and hospital care) but did not 
show important differences between treatment 
groups,10 and for this reason such information was 
not collected in Big CACTUS. However, informa-
tion on usual speech and language therapy care 
received during Big CACTUS was collected, allow-
ing an assessment of this aspect of usual care 
between randomised groups. The amount of care 
received was low, reduced through the trial period, 
and was comparable between groups.11 However, 
there was an indication that slightly less usual 
speech and language therapy was received in the 
computerised therapy plus usual care group, com-
pared to usual care alone (mean 3.2 hours across the 
six-month intervention period in the computerised 
therapy plus usual care group, compared to 3.8 hours 
in the usual care alone group).11 For context, a one-
hour reduction in speech and language therapist-
provided usual care equates to a cost saving of 
approximately £50 ($65) per patient, which would 
slightly reduce the ICER for computerised therapy 
plus usual care compared to usual care alone, from 
£40,164 ($52,259) per QALY gained to approxi-
mately £40,000 ($52,046) per QALY gained. 
Therefore, we expect that the impact of including 
usual care costs in our economic evaluation would 
have been minimal.
Including only direct intervention costs in our 
analysis also implies an assumption that there are no 
differences in indirect resource use associated with 
the intervention groups. Hence, potential knock-on 
effects on other healthcare appointments were 
excluded. We made this decision because Big 
CACTUS did not collect data on wider resource use, 
due to the pilot study finding no important differ-
ences in indirect resource use associated with com-
puterised therapy compared to usual care.10 This is 
in line with our expectation that the computerised 
therapy intervention evaluated would not have 
knock-on effects on other healthcare resource use.
It is important to note the potentially limited 
generalisability of our analysis. The computerised 
therapy studied focussed only on the treatment of 
word finding with one piece of software, and 
required speech and language therapists to tailor 
and personalise the software and train and support 
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volunteers and assistants to support patients. 
Different approaches to using computer therapy 
may have a different cost-effectiveness profile.
Conclusion
Although adding computerised therapy to usual 
care improves personally relevant word finding 
compared to usual care alone this does not trans-
late into appreciable health-related quality of life 
gains – with estimated gains small and uncertain. 
Consequently, the cost-effectiveness of the inter-
vention is uncertain. Further research is required 
to investigate how word finding improvements 
might lead to quality of life gains.
Clinical messages
•• Computerised therapy is unlikely to be 
cost-effective for the general population of 
people with aphasia post stroke. It is more 
likely to be cost-effective for people with 
mild or moderate aphasia.
•• Computerised therapy improves person-
ally relevant word finding but this does not 
translate into appreciable health-related 
quality of life gains.
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